Business / Finance

RSS

Mylan signs definitive agreement to acquire Famy Care's female health care businesses

Mylan Inc. today announced that it has, through its Indian subsidiary Mylan Laboratories Limited, signed a definitive agreement to acquire certain female health care businesses from Famy Care Limited, a specialty women's health care company with global leadership in generic oral contraceptive products (OCPs) for $750 million in cash plus additional contingent payments of up to $50 million.

2 Feb 2015

Concord Medical's shareholders adopt special resolution to create super voting class of shares

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that a special resolution was adopted by the Company's shareholders at its annual general meeting for the fiscal year ended December 31, 2014 held in Beijing on January 27, 2015 to create a super voting class of shares.

2 Feb 2015

Sutter Health reaches fair and reasonable agreement with Blue Shield of California

The not-for-profit Sutter Health network announced today that it reached agreement on a new two-year contract with Blue Shield of California, preserving patient access to the doctors and care centers that Blue Shield sold to patients during fall open enrollment.

31 Jan 2015

eRelevance closes seed funding of more than $1.4 million

eRelevance Corporation, announced today that it has closed a round of seed funding of more than $1.4 million.

31 Jan 2015

GNC Holdings declares quarterly cash dividend for first quarter 2015

The Board of Directors of GNC Holdings, Inc. authorized and declared the quarterly cash dividend for the first quarter of 2015 of $0.18 per share of the Company's common stock, representing a 12.5% increase over its prior quarterly dividend.

31 Jan 2015

JetFuel Technologies, Valtronic team up to reduce brain injuries

Valtronic develops partnerships built on the creation of innovative ideas, technology, and positive outcomes for all.

31 Jan 2015

Neuland Labs' revenues for third quarter of FY 2015 decrease 17% to $17.14 million

Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and custom manufacturing solutions services to customers located in 85 countries, today announced financial results for the third quarter of fiscal year (FY) 2015, ended December 31, 2014.

30 Jan 2015

Centura Health, DaVita HealthCare Partners jointly unveil FullWell

Centura Health and DaVita HealthCare Partners today unveiled FullWell, the brand name of the two partners' recently announced joint venture, a company that aims to bring greater value to health care and lower costs for consumers in Colorado and Kansas.

30 Jan 2015

TxCell receives milestone payment of EUR 1 million concerning Ovasave collaboration, license agreement from Trizell

TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA).

30 Jan 2015

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen.

30 Jan 2015

EKF Molecular Diagnostics collaborates with ANGLE for liquid biopsy development using Parsortix and PointMan technologies

EKF Molecular Diagnostics has agreed a collaboration with specialist medtech company ANGLE plc, to investigate the combination of ANGLE's Parsortix circulating tumour cell (CTC) harvesting platform with EKF Molecular's PointMan™ DNA enrichment technology as a liquid biopsy. If successful, the resulting simple blood test could enable the investigation of unexpected ultra-low level mutations in a patient's cancer for personalised cancer care.

29 Jan 2015

Park Systems announces innovations in bio cell analysis with the launch of Park NX-Bio

Park Systems, a leading manufacturer of atomic force microscopy (AFM) and nanoscale metrology products, proudly introduces Park NX-Bio, a powerful 3-in-1 bio-research tool that uniquely combines scanning ion conductance microscopy (SICM) with AFM and an inverted optical microscope (IOM) on the same platform.

29 Jan 2015

Marie Csete appointed president and chief scientist of HMRI

Huntington Medical Research Institutes, a leading biomedical research organization, has announced the appointment of Marie Csete, MD, PhD, its chief scientific officer, to her new role as president and chief scientist of HMRI.

29 Jan 2015

Biolin Scientific acquires the key patent protecting multi-hole, high-throughput ion channel screening

Biolin Scientific today announces the acquisition of a key patent related to performing multi-hole, high-throughput ion channel screening.

27 Jan 2015

genae announces acquisition of e-novex

genae, a global Contract Research Organization and services provider for the medical industries, announced today the acquisition of e-novex, a leading provider of electronic data tools that change medical research.

27 Jan 2015

Raiing Medical, Boston Children's Hospital sign license agreement for Thermia education platform

Raiing Medical Inc. and Boston Children's Hospital entered a license agreement for Boston Children's Thermia education platform, designed to assist parents in learning more about fever, illness and fever management. The online educational framework will be integrated with Raiing's iThermonitor device, a wearable thermometer with US FDA 510(k) clearance.

27 Jan 2015

University of Colorado, Mile High Ophthalmics sign licensing agreement for new cataract surgery device

A new device designed to perform safer, more effective cataract surgery is going on the market following a licensing agreement between the University of Colorado and Mile High Ophthalmics LLC.

27 Jan 2015

Innovent Biologics raises $100 million in Series C financing

Innovent Biologics, Inc., a privately held Chinese biopharmaceutical company dedicated to the development and manufacturing of complex, high-end biologics to be marketed in the rapidly growing Chinese market and elsewhere worldwide that meet EMEA and FDA/cGMP standards, has raised $100 million in Series C financing.

22 Jan 2015

Cypher Genomics, Sequenom sign development agreement for noninvasive prenatal tests

Cypher Genomics, Inc., the leading genome informatics company, and Sequenom, Inc., the leading molecular diagnostics company, today announced a development agreement for next generation noninvasive prenatal tests (NIPT).

22 Jan 2015

Heptares Therapeutics, AstraZeneca report significant progress in drug discovery collaboration

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, announces significant progress in its drug discovery collaboration with AstraZeneca.

22 Jan 2015

Business / Finance

Mylan signs definitive agreement to acquire Famy Care's female health care businesses

Concord Medical's shareholders adopt special resolution to create super voting class of shares

Sutter Health reaches fair and reasonable agreement with Blue Shield of California

eRelevance closes seed funding of more than $1.4 million

GNC Holdings declares quarterly cash dividend for first quarter 2015

JetFuel Technologies, Valtronic team up to reduce brain injuries

Neuland Labs' revenues for third quarter of FY 2015 decrease 17% to $17.14 million

Centura Health, DaVita HealthCare Partners jointly unveil FullWell

TxCell receives milestone payment of EUR 1 million concerning Ovasave collaboration, license agreement from Trizell

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

EKF Molecular Diagnostics collaborates with ANGLE for liquid biopsy development using Parsortix and PointMan technologies

Park Systems announces innovations in bio cell analysis with the launch of Park NX-Bio

Marie Csete appointed president and chief scientist of HMRI

Biolin Scientific acquires the key patent protecting multi-hole, high-throughput ion channel screening

genae announces acquisition of e-novex

Raiing Medical, Boston Children's Hospital sign license agreement for Thermia education platform

University of Colorado, Mile High Ophthalmics sign licensing agreement for new cataract surgery device

Innovent Biologics raises $100 million in Series C financing

Cypher Genomics, Sequenom sign development agreement for noninvasive prenatal tests

Heptares Therapeutics, AstraZeneca report significant progress in drug discovery collaboration

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News